Status:
UNKNOWN
Non-syndromic Inherited Anomalies of Mineralized Tooth Tissues: a Whole Exome Study to Identify New Pathogenic Variants
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
French rare diseases Healthcare Network
The French Foundation for Rare Diseases
Conditions:
Amelogenesis Imperfecta
Dentinogenesis Imperfecta
Eligibility:
All Genders
4+ years
Phase:
NA
Brief Summary
ExoDent specifically aims to discover new genes and new mutations causing isolated amelogenesis imperfecta (AI) and dentinogenesis imperfecta (DI) and other dentin anomalies. The key point for clinici...
Eligibility Criteria
Inclusion
- clinical diagnosis of amelogenesis imperfecta or dentinogenesis imerfecta or other dentin anomaly with no other signs or symptoms ( familial or isolated)
- negative results after targeted NGS strategy for molecular diagnosis
Exclusion
- absence of positive clinical diagnosis
- Diagnosis of syndromic disease
Key Trial Info
Start Date :
October 9 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2022
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT03810859
Start Date
October 9 2019
End Date
September 15 2022
Last Update
November 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Cochin
Paris, France, 75014